Maria Bruzelius

1.3k total citations · 1 hit paper
42 papers, 897 citations indexed

About

Maria Bruzelius is a scholar working on Hematology, Internal Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Maria Bruzelius has authored 42 papers receiving a total of 897 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Hematology, 21 papers in Internal Medicine and 8 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Maria Bruzelius's work include Venous Thromboembolism Diagnosis and Management (21 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Platelet Disorders and Treatments (12 papers). Maria Bruzelius is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (21 papers), Blood Coagulation and Thrombosis Mechanisms (16 papers) and Platelet Disorders and Treatments (12 papers). Maria Bruzelius collaborates with scholars based in Sweden, Norway and Finland. Maria Bruzelius's co-authors include Shuai Yuan, Susanna C. Larsson, Margareta Holmström, Jacob Odeberg, Anna Ågren, Ammar Majeed, Roza Chaireti, Maria Magnusson, Tony Frisk and Sam Schulman and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Maria Bruzelius

40 papers receiving 886 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of rivaroxaban- or apixaban-associated major bleeding with prothrombin complex concentrates: a cohort study

2017 234 citations Anna Ågren, Margareta Holmström et al. Blood profile →

Peers

Maria Bruzelius

CCM

HEMAT

GENET

Αnthi Travlou Greece

Galit Sarig Israel

Olga Panes Chile

Karin Strandberg Sweden

Katherine Marsden Australia

G. Freyburger France

Fernando Ferrando Spain

E G Bovill United States

Roumen Nakov Germany

R. Großmann Germany

Αnthi Travlou Greece

Maria Bruzelius

189 ×0.6

CCM

145 ×0.4

384 ×1.4

HEMAT

99 ×0.9

50 ×0.5

GENET

Citations per year, relative to Maria Bruzelius Maria Bruzelius (= 1×) peers Αnthi Travlou

Countries citing papers authored by Maria Bruzelius

Since Specialization

Citations

This map shows the geographic impact of Maria Bruzelius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Bruzelius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Bruzelius more than expected).

Fields of papers citing papers by Maria Bruzelius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Bruzelius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Bruzelius. The network helps show where Maria Bruzelius may publish in the future.

Co-authorship network of co-authors of Maria Bruzelius

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Bruzelius. A scholar is included among the top collaborators of Maria Bruzelius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Bruzelius. Maria Bruzelius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Oksanen, Anna, et al.. (2024). Out-of-hospital cardiac arrest associated with venous thromboembolism–a Swedish population-based cohort study. Journal of Thrombosis and Haemostasis. 23(3). 968–977.

Yuan, Shuai, Olga E. Titova, Ke Zhang, et al.. (2023). Plasma protein and venous thromboembolism: prospective cohort and mendelian randomisation analyses. British Journal of Haematology. 201(4). 783–792. 23 indexed citations

Baghaei, Fariba, Maria Bruzelius, Pål André Holme, et al.. (2023). No difference in quality of life between persons with severe haemophilia A and B. Haemophilia. 29(4). 987–996. 4 indexed citations

Warnqvist, Anna, et al.. (2023). POS1512 THROMBOCYTOPENIA AND IMPAIRED KIDNEY FUNCTION ARE MAJOR RISK FACTORS FOR RECURRENT THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME. Annals of the Rheumatic Diseases. 82. 1115–1115.

Berntorp, Erik, Jan Astermark, Anna Olsson, et al.. (2023). Health‐related quality of life and physical activity in Nordic patients with moderate haemophilia A and B (the MoHem study). Haemophilia. 30(1). 98–105. 2 indexed citations

Goumidi, Louisa, Astrid van Hylckama Vlieg, Maria Bruzelius, et al.. (2023). Association of ABO blood groups with venous thrombosis recurrence in middle-aged patients: insights from a weighted Cox analysis dedicated to ambispective design. BMC Medical Research Methodology. 23(1). 99–99. 2 indexed citations

Yuan, Shuai, Jie Chen, Tian Fu, et al.. (2023). Ultra-processed food intake and incident venous thromboembolism risk: Prospective cohort study. Clinical Nutrition. 42(8). 1268–1275. 3 indexed citations

Baghaei, Fariba, Maria Bruzelius, Pål André Holme, et al.. (2022). Factor IX antibodies and tolerance in hemophilia B in the Nordic countries – The impact of F9 variants and complications. Thrombosis Research. 217. 22–32. 1 indexed citations

Yuan, Shuai, Maria Bruzelius, Scott M. Damrauer, et al.. (2022). Anti-inflammatory diet and incident peripheral artery disease: Two prospective cohort studies. Clinical Nutrition. 41(6). 1191–1196. 11 indexed citations

10.

Smith, Philip B., Axel Rosell, Maria Bruzelius, et al.. (2022). Markers of neutrophil activation and neutrophil extracellular traps in diagnosing patients with acute venous thromboembolism: A feasibility study based on two VTE cohorts. PLoS ONE. 17(7). e0270865–e0270865. 14 indexed citations

11.

Sjöström, Anna, Anna Warnqvist, Maria Magnusson, et al.. (2021). Platelet Count Rose While D-Dimer Levels Dropped as Deaths and Thrombosis Declined—An Observational Study on Anticoagulation Shift in COVID-19. Thrombosis and Haemostasis. 121(12). 1610–1621. 14 indexed citations

12.

Bruzelius, Maria, et al.. (2021). In-hospital cardiac arrest due to pulmonary embolism – Treatment and outcomes in a Swedish cohort study. Resuscitation Plus. 8. 100178–100178. 3 indexed citations

13.

Yuan, Shuai, Maria Bruzelius, & Susanna C. Larsson. (2021). Causal effect of renal function on venous thromboembolism: a two-sample Mendelian randomization investigation. Journal of Thrombosis and Thrombolysis. 53(1). 43–50. 4 indexed citations

14.

Yuan, Shuai, Paul Carter, Maria Bruzelius, et al.. (2020). Effects of tumour necrosis factor on cardiovascular disease and cancer: A two-sample Mendelian randomization study. EBioMedicine. 59. 102956–102956. 100 indexed citations

15.

Schmidt, David E., Roza Chaireti, Maria Bruzelius, et al.. (2019). Correlation of thromboelastography and thrombin generation assays in warfarin-treated patients. Thrombosis Research. 178. 34–40. 22 indexed citations

16.

Grosso, Giorgia, Barry Woodhams, Katarina Bremme, et al.. (2017). Thrombin activatable fibrinolysis inhibitor (TAFI) — A possible link between coagulation and complement activation in the antiphospholipid syndrome (APS). Thrombosis Research. 158. 168–173. 13 indexed citations

17.

Bruzelius, Maria, María Jesús Iglesias, Laura Sánchez‐Rivera, et al.. (2016). PDGFB, a new candidate plasma biomarker for venous thromboembolism: results from the VEREMA affinity proteomics study. Blood. 128(23). e59–e66. 40 indexed citations

18.

Bruzelius, Maria, Rona J. Strawbridge, David‐Alexandre Trégouët, et al.. (2014). Influence of coronary artery disease-associated genetic variants on risk of venous thromboembolism. Thrombosis Research. 134(2). 426–432. 15 indexed citations

19.

Svenungsson, Elisabet, Anna Ågren, Fariborz Mobarrez, et al.. (2014). Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome. Thrombosis Research. 133(5). 936–944. 20 indexed citations

20.

Bruzelius, Maria, Matteo Bottai, Maria Sabater‐Lleal, et al.. (2014). Predicting venous thrombosis in women using a combination of genetic markers and clinical risk factors. Journal of Thrombosis and Haemostasis. 13(2). 219–227. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact